Carmine N. Stengone
Director; Director, CEO and President · 6 filings · Latest: Jul 8, 2026
Contineum Therapeutics, Inc.
KIORA PHARMACEUTICALS INC
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
CTNM | Carmine N. Stengone | Director, CEO and President | Jul 8, 2026 | Sale | $16.00 | 2,500 | $40.0K | 17,217 | |
CTNM | Carmine N. Stengone | Director, CEO and President | Jul 8, 2026 | Option Exercise | $1.01 | 2,500 | $2.5K | 19,717 | |
CTNM | CARMINE STENGONE | — | Jul 8, 2026 | Proposed Sale | $14.56 | 2,500 | $36.4K | — | |
CTNM | Carmine N. Stengone | Director, CEO and President | Jun 30, 2026 | Sale | $16.01 | 10,000 | $160.1K | 17,217 | |
CTNM | Carmine N. Stengone | Director, CEO and President | Jun 30, 2026 | Option Exercise | $1.07 | 10,000 | $10.7K | 27,217 | |
CTNM | CARMINE STENGONE | — | Jun 30, 2026 | Proposed Sale | $15.00 | 10,000 | $150.0K | — | |
CTNM | Carmine N. Stengone | Director, CEO and President | Feb 25, 2026 | Sale | $16.02 | 2,700 | $43.2K | 14,954 | |
CTNM | Carmine N. Stengone | Director, CEO and President | Feb 25, 2026 | Option Exercise | $1.26 | 2,700 | $3.4K | 17,654 | |
CTNM | Carmine N. Stengone | Director, CEO and President | Feb 24, 2026 | Sale | $16.02 | 4,400 | $70.5K | 14,954 | |
CTNM | Carmine N. Stengone | Director, CEO and President | Feb 24, 2026 | Option Exercise | $1.26 | 4,400 | $5.5K | 19,354 | |
CTNM | Carmine N. Stengone | Director, CEO and President | Feb 11, 2026 | Sale | $16.00 | 400 | $6.4K | 14,954 | |
CTNM | Carmine N. Stengone | Director, CEO and President | Feb 11, 2026 | Option Exercise | $1.26 | 400 | $504 | 15,354 | |
CTNM | CARMINE STENGONE | — | Feb 11, 2026 | Proposed Sale | $15.75 | 7,500 | $118.1K | — |